Trial Profile
A prospective, Single Blind, Multi-center, Randomized Trial to Compare the TAXUS Element_ Coronary Stent System against the XIENCE Prime_ Coronary Stent System in the treatment of a Diabetic Patient PopulatiOn in India.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Everolimus
- Indications Coronary artery disease; Coronary artery restenosis; Ischaemia
- Focus Therapeutic Use
- Acronyms TUXEDO
- 14 Oct 2015 Primary endpoint has not been met. (Target vessel failure rate), as per an article published in the New England Journal of Medicine
- 14 Oct 2015 Status changed from recruiting to completed, as per an article published in the New England Journal of Medicine
- 14 Oct 2015 Results published in the New England Journal of Medicine